ONYI DURUJI: Open Payments
NPI 1609409655 · KATY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$736 in 10 payments from 6 companies in 2025. Trend: 2023 $528 · 2024 $354 · 2025 $736
Food & beverage: $736
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 4 | $338 |
| Axsome Therapeutics, Inc. | 2 | $135 |
| Neurocrine BioSciences, Inc. | 1 | $99 |
| E.R. Squibb & Sons, L.L.C. | 1 | $97 |
| Novartis Pharmaceuticals Corporation | 1 | $34 |
| Janssen Pharmaceuticals, Inc | 1 | $33 |
Products named: LYBALVI, ARISTADA, Auvelity, INGREZZA, COBENFY, KESIMPTA, INVEGA SUSTENNA.
Industry payments across TX — which companies pay providers there.
